Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 1:40 AM
NCT ID: NCT01873794
Eligibility Criteria: Inclusion Criteria: Patients: * With a history of HSCT as treatment for hematological malignancies and related diseases and who are up to 3.5 years post-transplant; OR * Who are up to three and a half years post completion of chemotherapy OR chemotherapy and radiation for breast cancer with a curative intent; AND: * With a score equal to or less than 33 on the FACIT-Fatigue scale (see below) and no pre-existing anemia (Hb\<10gm/dl); or a score equal to or greater than 43 on the Cognitive Failures Questionnaire * Who are currently over age 18 and at least age 16 at the time of HSCT or time of breast cancer treatment Exclusion Criteria: * Under age 18; * Pregnancy; * Confounding underlying medical illnesses; * History of mania (which is a contra-indication for light treatment) or current clinical depression; * And any other physical or psychological impairments including a sleep disorder diagnosis which would limit participation.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT01873794
Study Brief:
Protocol Section: NCT01873794